Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-25-056386
Filing Date
2025-04-21
Accepted
2025-04-21 17:19:32
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-21

Document Format Files

Seq Description Document Type Size
1 ARS alxo_2024_ars.pdf ARS 4005286
  Complete submission text file 0000950170-25-056386.txt   5516394
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

EIN.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39386 | Film No.: 25854415
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)